iCoreConnect Inc. Common stock (ICCT) - Total Liabilities
Based on the latest financial reports, iCoreConnect Inc. Common stock (ICCT) has total liabilities worth $17.24 Million USD as of September 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
iCoreConnect Inc. Common stock - Total Liabilities Trend (2006–2023)
This chart illustrates how iCoreConnect Inc. Common stock's total liabilities have evolved over time, based on quarterly financial data. See ICCT current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
iCoreConnect Inc. Common stock Competitors by Total Liabilities
The table below lists competitors of iCoreConnect Inc. Common stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Norcros Plc
LSE:NXR
|
UK | GBX175.00 Million |
|
Geekco Technologies Corp
V:GKO
|
Canada | CA$2.55 Million |
|
Heavy Rare EARTHS Ltd
AU:HRE
|
Australia | AU$442.38K |
|
Abits Group Inc.
NASDAQ:ABTS
|
USA | $3.13 Million |
|
Rebosis Property Fund Ltd
JSE:REA
|
South Africa | ZAC10.18 Billion |
|
Volcanic Gold Mines Inc
V:VG
|
Canada | CA$264.50K |
|
Nawarat Patanakarn Public Company Limited
BK:NWR
|
Thailand | ฿15.42 Billion |
Liability Composition Analysis (2006–2023)
This chart breaks down iCoreConnect Inc. Common stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see iCoreConnect Inc. Common stock (ICCT) market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.11 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -5.71 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.21 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how iCoreConnect Inc. Common stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for iCoreConnect Inc. Common stock (2006–2023)
The table below shows the annual total liabilities of iCoreConnect Inc. Common stock from 2006 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | $11.24 Million | +24.12% |
| 2022-12-31 | $9.06 Million | +61.02% |
| 2021-12-31 | $5.63 Million | +69.45% |
| 2020-12-31 | $3.32 Million | +61.38% |
| 2019-12-31 | $2.06 Million | -23.62% |
| 2018-12-31 | $2.69 Million | -8.53% |
| 2017-12-31 | $2.94 Million | -0.64% |
| 2016-12-31 | $2.96 Million | -78.26% |
| 2015-12-31 | $13.63 Million | +2.37% |
| 2013-12-31 | $13.31 Million | +63.65% |
| 2012-12-31 | $8.13 Million | +54.08% |
| 2011-12-31 | $5.28 Million | -39.11% |
| 2010-12-31 | $8.67 Million | +29.63% |
| 2009-12-31 | $6.69 Million | +35.29% |
| 2008-12-31 | $4.94 Million | +55.88% |
| 2006-12-31 | $3.17 Million | -- |
About iCoreConnect Inc. Common stock
iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history… Read more